Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 07 2021
Historique:
received: 07 02 2021
accepted: 28 06 2021
entrez: 27 7 2021
pubmed: 28 7 2021
medline: 4 11 2021
Statut: epublish

Résumé

To study the outer retina morpho-functional characteristics and the choriocapillaris (CC) features in type 1 diabetic (T1D) patients, with and without signs of diabetic retinopathy (NPDR and NoDR). Twenty-five NPDR and 18 NoDR eyes were imaged by Optical Coherence Tomography Angiography. Ellipsoid zone (EZ) "normalized" reflectivity and CC perfusion density parameters, as flow deficits number (FDn), flow deficit average area (FDa) and flow deficit percentage (FD%), were analysed. Multifocal electroretinogram (mfERG) response amplitude densities (RADs) were measured. Mean EZ "normalized" reflectivity, CC FDn and FD% values, were similar (p > 0.05) in both groups, FDa was significant greater (p > 0.05) in NPDR compared with NoDR eyes. MfERG-RADs were similar in both groups. NPDR eyes showed a significant (p < 0.05) linear correlation between RADs and both, CC FDa and FD%. The EZ "normalized" reflectivity was negatively correlated with CC FD% in NoDR eyes. In NPDR T1D eyes a significant relationship between abnormal outer retina functional responses and CC impairment was observed, while in NoDR eyes the photoreceptor reflectivity was correlated to CC abnormalities. The outer retina dysfunction in NPDR correlated to CC drop-out let hypothesize that the outer retinal elements are functionally impaired in proportion to the CC vascular supply deficit.

Identifiants

pubmed: 34312425
doi: 10.1038/s41598-021-94580-z
pii: 10.1038/s41598-021-94580-z
pmc: PMC8313686
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15183

Informations de copyright

© 2021. The Author(s).

Références

Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD25-AMD30
pubmed: 29860309
Invest Ophthalmol Vis Sci. 2012 Sep 07;53(10):6017-24
pubmed: 22879414
Am J Ophthalmol. 2017 Sep;181:1-11
pubmed: 28624323
Am J Ophthalmol. 2017 Jul;179:90-96
pubmed: 28483496
Arch Ophthalmol. 1984 Apr;102(4):520-6
pubmed: 6367724
Am J Ophthalmol. 2018 Dec;196:34-43
pubmed: 30118688
Retina. 2012 Oct;32(9):1781-90
pubmed: 22869022
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1236-49
pubmed: 8641827
Retina. 2020 Mar;40(3):412-420
pubmed: 30576300
Am J Ophthalmol. 2016 Aug;168:129-138
pubmed: 27173374
Ophthalmol Retina. 2017 Mar-Apr;1(2):124-136
pubmed: 28584883
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):11
pubmed: 32396630
JAMA Ophthalmol. 2017 Nov 1;135(11):1197-1204
pubmed: 28983552
Doc Ophthalmol. 2013 Dec;127(3):217-25
pubmed: 23943132
Retina. 2020 Jun;40(6):1062-1069
pubmed: 30986798
Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1696-704
pubmed: 17557923
Acta Diabetol. 2018 Nov;55(11):1191-1200
pubmed: 30159747
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO307-BIO315
pubmed: 29059262
Ophthalmology. 1991 May;98(5 Suppl):807-22
pubmed: 2062514
Clin Neurophysiol. 2010 Mar;121(3):380-5
pubmed: 20071230
Ophthalmic Surg Lasers Imaging Retina. 2013 Nov-Dec;44(6 Suppl):S5-10
pubmed: 24220885
Retina. 2017 Jan;37(1):11-21
pubmed: 27557084
Prog Retin Eye Res. 2003 Mar;22(2):201-51
pubmed: 12604058
Sci Rep. 2018 Oct 24;8(1):15694
pubmed: 30356090
Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):523-30
pubmed: 26057755
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):50
pubmed: 32232345
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4343-4410
pubmed: 29126250
Doc Ophthalmol. 2012 Feb;124(1):1-13
pubmed: 22038576
Invest Ophthalmol Vis Sci. 2012 Oct 09;53(11):7071-6
pubmed: 22977133
Retina. 2020 Feb;40(2):333-344
pubmed: 31972804
Br J Ophthalmol. 2019 Sep;103(9):1320-1326
pubmed: 30361273
PLoS One. 2020 Dec 11;15(12):e0243830
pubmed: 33306736
Br J Ophthalmol. 2004 Aug;88(8):1060-3
pubmed: 15258025
Am J Ophthalmol. 2020 May;213:161-176
pubmed: 32059979

Auteurs

M Parravano (M)

IRCCS - Fondazione Bietti, Rome, Italy.

L Ziccardi (L)

IRCCS - Fondazione Bietti, Rome, Italy.

E Borrelli (E)

Department of Ophthalmology, IRCCS Ospedale San Raffaele, University Vita-Salute, Via Olgettina, 60, Milan, Italy.

E Costanzo (E)

IRCCS - Fondazione Bietti, Rome, Italy.

S Frontoni (S)

Unit of Endocrinology, Diabetes and Metabolism, S. Giovanni Calibita Fatebenefratelli Hospital, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

F Picconi (F)

Unit of Endocrinology, Diabetes and Metabolism, S. Giovanni Calibita Fatebenefratelli Hospital, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

V Parisi (V)

IRCCS - Fondazione Bietti, Rome, Italy.

R Sacconi (R)

Department of Ophthalmology, IRCCS Ospedale San Raffaele, University Vita-Salute, Via Olgettina, 60, Milan, Italy.

A Di Renzo (A)

IRCCS - Fondazione Bietti, Rome, Italy.

M Varano (M)

IRCCS - Fondazione Bietti, Rome, Italy.

G Querques (G)

Department of Ophthalmology, IRCCS Ospedale San Raffaele, University Vita-Salute, Via Olgettina, 60, Milan, Italy. giuseppe.querques@hotmal.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH